Neurology, Neuropsychiatry, Psychosomatics

Advanced search

Effects of etifoxine: Chemoreactome simulation

Full Text:


Etifoxine modulates GABAergic transmission and is used as an anxiolytic (anti-anxiety) medication. The indications for etifoxine use are anxiety, fear and inner tension.

Objective: to simulate the biological properties of etifoxine. This simulation has been carried out for the first time.

Material and methods. Reliable estimates of more than 2,500 biological activities were obtained for this molecule, which were compared with the reference drug lorazepam (benzodiazepine).

Results and discussion. The data obtained from chemoreactome simulation may suggest that there are significant differences between the pharmacological effects of etifoxine and benzodiazepine in: 1) the selectivity of binding to various neurotransmitter receptors; 2) anti-inflammatory activity; 3) the effect on hemodynamics and vascular walls; 4) negative side effects and 5) pharmacokinetic parameters.

Conclusion. The findings are consistent with the available experimental and clinical data and are indicative of promising clinical applications of etifoxine. 

About the Authors

I. Yu. Torshin
Moscow Institute of Physics and Technology, Dolgoprudnyi
Russian Federation

9, Institutskiy Lane, Dolgoprudnyi, Moscow Region 141700

O. A. Gromova
Ivanovo State Medical Academy, Ministry of Health of Russia, Ivanovo
Russian Federation

8, Sheremetevsky Passage., Ivanovo 153000

L. E. Fedotova
Ivanovo State Medical Academy, Ministry of Health of Russia, Ivanovo
Russian Federation

8, Sheremetevsky Passage., Ivanovo 153000

A. N. Gromov
Federal Research Center «Information Science and Management», Russian Academy of Sciences», Moscow
Russian Federation

44/2, Vavilov St., Moscow 119333 


1. Kruse HJ, Kuch H. Etifoxine: evaluation of its anticonvulsant profile in mice in comparison with sodium valproate, phenytoin and clobazam. Arzneimittelforschung. 1985;35(1):133-5.

2. Beльтищeв ДЮ. Диагностика и фармакотерапия тревожного варианта расстройства адаптации: анксиолитик этифоксин (Стрезам) в клинических и экспериментальных исследованиях. Социальная и клиническая психиатрия. 2010;(1):86-90. [Vel'tishchev DYu. Diagnosis and pharmacotherapy alarming adaptation disorders: anxiolytic etifoxine (Stresam) in clinical and experimental studies. Sotsial'naya i klinicheskaya psikhiatriya. 2010;(1):86-90. (In Russ.)].

3. Torshin IYu. Bioinformatics in the postgenomic era: sensing the change from molecular genetics to personalized medicine. New York: Nova Biomedical Books; 2009.

4. Torshin IYu, Rudakov KV. On the application of the combinatorial theory of solvability to the analysis of chemographs. Part 1: fundamentals of modern chemical bonding theory and the concept of the chemograph. Pattern Recognition and Image Analysis. 2014;24(1):11-23.

5. Torshin IYu, Rudakov KV. On the application of the combinatorial theory of solvability to the analysis of chemographs. Part 2: Local completeness of invariants of chemographs in view of the combinatorial theory of solvability. Pattern Recognition and Image Analysis (Advances in Mathematical Theory and Applications). 2014;24(2):196-208.

6. Журавлeв ЮИ, Рудаков КВ, Торшин ИЮ. Алгебраические критерии локальной разрешимости и регулярности как инструмент исследования морфологии аминокислотных последовательностей. Труды МФТИ. 2011;3(4):67-76. [Zhuravlev YuI, Rudakov KV, Torshin IYu. Algebraic criteria for local solvability and regularity as a tool to investigate the morphology of amino acid sequences. Trudy MFTI. 2011;3(4):67-76. (In Russ.)].

7. Рудаков КВ, Торшин ИЮ. Об отборе информативных значений признаков на базе критериев разрешимости в задаче распознавания вторичной структуры белка. ДАН. 2011;441(1):1-5. [Rudakov KV, Torshin IYu. About the selection of informative characteristic values on the basis of criteria of solvability in the problem of protein secondary structure recognition. DAN. 2011;441(1):1-5. (In Russ.)].

8. Torshin IYu. On solvability, regularity, and locality of the problem of genome annotation. Pattern Recognition and Image Analysis. 2010;20(3):386-95.

9. Журавлев ЮИ. Теоретико-множественные методы в алгебре логики. Проблемы кибернетики. 1962;8(1):25-45. [Zhuravlev YuI. Set-theoretic methods in the algebra of logic. Problemy kibernetiki. 1962;8(1):25-45. (In Russ.)].

10. Bolton EE, Chen J, Kim S, et al. PubChem3D: a new resource for scientists. J Cheminform. 2011 Sep 20;3(1):32. doi: 10.1186/1758-2946-3-32.

11. Wishart DS, Knox C, Guo AC, et al. HMDB: a knowledgebase for the human metabolome. Nucleic Acids Res. 2009 Jan;37(Database issue):D603-10. doi: 10.1093/nar/gkn810. Epub 2008 Oct 25.

12. Choi YM, Kim KH. Etifoxine for pain patients with anxiety. Korean J Pain. 2015 Jan;28(1):4-10. doi: 10.3344/kjp.2015.28.1.4. Epub 2015 Jan 2.

13. Bouillot C, Bonnefoi F, Liger F, Zimmer L. A microPET comparison of the effects of etifoxine and diazepam on [11C]flumazenil uptake in rat brains. Neurosci Lett. 2016 Jan 26;612:74-9. doi: 10.1016/j.neulet.2015.11.042. Epub 2015 Nov 28.

14. Stein DJ. Etifoxine versus alprazolam for the treatment of adjustment disorder with anxiety: a randomized controlled trial. Adv Ther. 2015 Jan;32(1):57-68. doi: 10.1007/s12325- 015-0176-6. Epub 2015 Jan 27.

15. Zeitler A, Kamoun N, Goyon S, et al. Favoring inhibitory synaptic drive mediated by GABA receptors in the basolateral nucleus of the amygdala efficiently reduces pain symptoms in neuropathic mice. Eur J Neurosci. 2016 Apr;43(8):1082-8. doi: 10.1111/ejn.13217. Epub 2016 Mar 17.

16. Verleye M, Heulard I, Nuss P, Gillardin JM. Effects of stress and etifoxine on pentobarbitalinduced loss of righting reflex in Balb/cByJ and C57BL/6J mice. Neurosci Lett. 2003 Dec 19;353(2):127-30.

17. Ozawa M, Nakada Y, Sugimachi K. Interaction of the hypnotic lormetazepam with central benzodiazepine receptor subtypes omega 1, omega 2 and omega 3. Nihon Yakurigaku Zasshi. 1991 Nov;98(5):399-408.

18. Haring M, Kaiser N, Monory K, Lutz B. Circuit specific functions of cannabinoid CB1 receptor in the balance of investigatory drive and exploration. PLoS One. 2011;6(11):e26617. doi: 10.1371/journal.pone.0026617. Epub 2011 Nov 1.

19. Micallef J, Soubrouillard C, Guet F, et al. A double blind parallel group placebo controlled comparison of sedative and mnesic effects of etifoxine and lorazepam in healthy subjects [corrected]. Fundam Clin Pharmacol. 2001 Jun;15(3):209-16.

20. Miwatashi S, Arikawa Y, Matsumoto T, et al. Synthesis and biological activities of 4-phenyl- 5-pyridyl-1,3-thiazole derivatives as selective adenosine A3 antagonists. Chem Pharm Bull (Tokyo). 2008 Aug;56(8):1126-37.

21. Ravikumar B, Crawford D, Dellovade T, et al. Differential efficacy of the TSPO ligands etifoxine and XBD-173 in two rodent models of Multiple Sclerosis. Neuropharmacology. 2016 Mar 30. pii: S0028-3908(16)30125-3. doi: 10.1016/j.neuropharm.2016.03.053. [Epub ahead of print].

22. Girard P, Pansart Y, Gillardin JM. Preventive and curative effects of etifoxine in a rat model of brain oedema. Clin Exp Pharmacol Physiol. 2009 Jul;36(7):655-61. doi: 10.1111/j. 1440-1681.2008.05127.x. Epub 2009 Nov 28.

23. Gaikwad AB, Viswanad B, Ramarao P. PPAR gamma agonists partially restores hyperglycemia induced aggravation of vascular dysfunction to angiotensin II in thoracic aorta isolated from rats with insulin resistance. Pharmacol Res. 2007 May;55(5):400-7. Epub 2007 Feb 2.

24. Lechin F, van der Dijs B, Benaim M. Benzodiazepines: tolerability in elderly patients. Psychother Psychosom. 1996;65(4):171-82.

25. Braga RC, Alves VM, Silva MF, et al. Tuning HERG out: antitarget QSAR models for drug development. Curr Top Med Chem. 2014;14(11):1399-415.

26. Sanguinetti MC, Tristani-Firouzi M. hERG potassium channels and cardiac arrhythmia. Nature. 2006 Mar 23;440(7083):463-9.

27. Торшин ИЮ, Громова ОА. Экспертный анализ данных в молекулярной фармакологии. Москва: МЦНМО; 2012. 768 с. [Torshin IYu, Gromova OA. Ekspertnyi analiz dannykh v molekulyarnoi farmakologii [Expert data analysis in molecular pharmacology]. Moscow: MTsNMO; 2012. 768 p.]

For citation:

Torshin I.Yu., Gromova O.A., Fedotova L.E., Gromov A.N. Effects of etifoxine: Chemoreactome simulation. Neurology, Neuropsychiatry, Psychosomatics. 2016;8(2):44-49. (In Russ.)

Views: 301

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.

ISSN 2074-2711 (Print)
ISSN 2310-1342 (Online)